Dr. Pei-Chen Chang


Academic Degree(s)






Current Position

Attending Physician, China Medical University Hospital


Professional Experience

  • Attending Psychiatrist, Department of Psychiatry, China Medical University Hospital, Taiwan (since 2009.7)
  • Clinical Lecturer (Part-time), College of Medicine, China Medical University, Taiwan (Since 2012.8)
  • Consultant, National Taichung Girls Senior High School, Taiwan (Since 2009.2)


Education & Training

  • MD in Medicine, China Medical University, Taiwan (2008-2005)
  • MSc in Clinical Medicine, Institute of Clinical Medical Sciences, China Medical University, Taiwan (2009-2011)
  • PhD student, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK (since 2016)



  • 2015, Sartorius Award, The 5th World Congress of Asian Psychiatry (WCAP), Japan.
  • 2015, The 2015 Helmut Remschmidt Research Seminar (HRRS) Fellowship Award, Canada.
  • 2015, Dr. Paul Janssen Research Paper Award, The Taiwanese Society of Biological Psychiatry & Neuropsychopharmacology, Taiwan.
  • 2016, 2016 British Association for Psychopharmacology (BAP)Junior Clinical BAP Psychopharmacology Award, UK.


Research Grants

  • Ministry of Science & Technology-Taiwan 01/08/2015-30/06-2018, 
    To investigate omega-3 PUFAs in cardiovascular diseases comorbid depression
  • Ministry of Science & Technology- Su (PI) 01/08/2009-31/07/2012, 
    To investigate omega-3 in Interferon-alpha induced depression


Committee & Membership

  • 2008-Present, Executive Committee, Taiwan Young Psychiatrists Organization (TYPO)
  • 2015-Present, Country Coordinator (Taiwan), Young Psychiatrists Network (YPN)
  • 2016-2019, Member of Board of Directors, the Taiwan Society for Nutritional Psychiatry Research TSNPR)


Selected Publication

  • Chang JP, Guu TW, Chen YC, Galecki P, Walczewska A, Su KP. BanI Polymorphism of Cytosolic Phospholipase A2 Gene and Somatic Symptoms in Medication- Free Acute Depressed Patients. Prostaglandins Leukotrienes and Essential Fatty Acids. 2017 Jan 4 (Accepted).(SCI: 3.155)
  • Chang JP, Gau SS. Mother-Child Relationship in Youths with Attention-Deficit Hyperactivity Disorder and Their Siblings. J Abnorm Child Psychol. 2017; 45:871-882.(SCI: 3.579)
  • Chang JP, Jingling L, Huang YT, Lu YJ, Su, KP. Delay Aversion, Temporal Processing, and N-3 Fatty Acids, Intake in Children with Attention-Deficit/Hyperactivity Disorder (ADHD). Clinical Psychological Science 2016; 1094-1103
  • Chang JP, Lai HC, Yang HT, Su WP, Peng CY, Gałecki P, Walczewska A, Pariante CM, Su KP. Polyunsaturated fatty acids levels and initial presentation of somatic symptoms induced by interferon-alpha therapy in patients with chronic hepatitis C viral infection. Nutritional Neuroscience 2017; 20: 291-296 (SCI:2.616)
  • Chang JP, Chang SS, Yang HT, Palani M, Chen CP, Su KP. Polyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular diseases (CVDs) with and without depression. Brain Behavior and Immunity 2015;44:28-31.(SCI: 5.874)
  • Chang JP, Lane HY, Tsai GE. Attention Deficit Hyperactivity Disorder and N-methyl-D-aspartate (NMDA) Dysregulation. Current Pharmaceutical Design 2014; 20(32)5180-5. (SCI1.54)
  • Su KP, Lai HC, Yang HT, Su WP, Peng CY, Chang JP, Chang HC, Pariante CM. Omega-3 Fatty Acids in the Prevention of Interferon-Alpha-Induced Depression: Results from a Randomized Controlled Trial. Biological Psychiatry 2014; 76(7):559-66. (SCI: 11.212)
  • Gau SS*, Chang JP. Maternal parenting styles and mother-child relationships among adolescents with and without persistent attention-deficit/hyperactivity disorder. Research in Developmental Disabilities 2013, 34(5): 1581-94. (SCI: 1.877) (shared first author)
  • Kato TA, Shinfuku N, Fujisawa D, Tateno M, Ishida T, Akiyama T, Sartorius N, Teo AR, Choi TY, Wand A, Balhara YPS, Chang JP, Chang RF, Shadloo B, Ahmed HU, Lerthattasilp T, Umene- Nakano W, Horikawa H, Ryohei Matsumoto R, Kuga H, Tanaka M, Kanba S. Introducing the concept of modern depression in Japan; an international case vignette survey. Journal of Affective Disorder 2011, 135(1-3):66-76. (SCI:3.570)
  • Kato TA, Tateno M, Shinfuku N, Fujisawa D, Teo AR; Sartorius N, Akiyama T, Ishida T, Choi TY, BalharaYPS, Matsumoto R, Umene-Nakano W, Fujimura Y, Wand A, Chang JP, Chang RY, Shadloo B, Ahmed HU, Lerthattasilp T, Kanba S. Does the 'hikikomori' syndrome of social withdrawal exist outside Japan?: A preliminary international investigation. Social Psychiatry and Psychiatric Epidemiology 2011, 47(7): 1061-75. (SCI 2.513)